Mangharal, Victor C.
HRN: 24-79-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/09/2024
04/16/2024
IV
500mg
Every 8 Hours
T/c Ruptured Appendicitis With Generalized Peritonitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes